Clinical Trials Directory

Trials / Unknown

UnknownNCT04326517

Factors Associated To Intensive Care Admission And Mortality In Patients With Emphysematous Pyelonephritis

Microbiologic Profile And Factors Associated To Intensive Care Admission And Mortality In Patients With Emphysematous Pyelonephritis: A 10-Year Experience In A Tertiary Care Center

Status
Unknown
Phase
Study type
Observational
Enrollment
65 (estimated)
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Emphysematous pyelonephritis is a lifethreatening necrotizing infection of the kidney characterized by accumulation of gas in the renal parenchyma and within the surrounding tissues. The aim of the study is to report the outcome of the management of this condition at the investigators institution and to determine the microbiological characteristics, antibiotic resistance patterns, and to analyze factors predicting mortality and intensive care unit admission.

Detailed description

The investigators are planning to perform a retrospective study analyzing cases of emphysematous pyelonephritis from a single tertiary care institution in the north of Mexico in the period of 2011-2021. The diagnosis of emphysematous pyelonephritis is confirmed by computed tomography. Demographic, clinical, biochemical, therapeutic management, and outcomes will be collected. Variables will be analyzed to determine factors associated with admission to intensive care unit and mortality. Urine cultures will be analyzed and drug resistance profile will be determined using microdilution plate. Clinical and demographic characteristics will be analyzed using Chi square test for categorical variables, and T-test for numerical variables. Statistical significance is set at p\<0.05. Statistical analysis will be performed with the SPSS software version 20.0.

Conditions

Interventions

TypeNameDescription
PROCEDURENephrectomyDifferent therapeutic options are described in literature for emphysematous pyelonephritis. In our center, medical treatment (no invasive procedure), ureteral stent (endourologic procedure), percutaneous drainage (minimally invasive procedure), and nephrectomy are the therapeutic options for this disease.

Timeline

Start date
2020-04-01
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2020-03-30
Last updated
2020-04-01

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04326517. Inclusion in this directory is not an endorsement.